Stockscreener 앱 받기
2.89
0.00%
0.00
시간 외 거래:
2.86
-0.03
-1.04%
전일 마감가:
$2.89
열려 있는:
$2.86
하루 거래량:
53,262
Relative Volume:
0.02
시가총액:
$9.90M
수익:
$3.57M
순이익/손실:
$-15.74M
주가수익비율:
-0.4159
EPS:
-6.9481
순현금흐름:
$-15.77M
1주 성능:
-6.17%
1개월 성능:
-40.53%
6개월 성능:
-84.24%
1년 성능:
-90.56%
1일 변동 폭
$2.80
$3.09
1주일 범위
$2.71
$3.24
52주 변동 폭
$2.12
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
2.89 | 9.87M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd 주식(ICCM)의 최신 뉴스
Icecure Medical Ltd (ICCM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Icecure Medical Ltd (ICCM) Institutional Confidence - TradingKey
Icecure Medical Ltd (ICCM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IceCure Medical Kicks Off Post-Marketing ChoICE Study for ProSense Cryoablation in Low-Risk Breast Cancer Treatment at First U.S. Clinical Site - marketscreener.com
Icecure Medical Ltd (ICCM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Icecure Medical Ltd (ICCM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IceCure Medical launches U.S. post-marketing st... - Pluang
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site - PR Newswire
Icecure Medical Ltd (ICCM) Cash Flow - TradingKey
IceCure Medical Ltd. Revenue Breakdown – NASDAQ:ICCM - TradingView
Icecure Medical Ltd (ICCM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IceCure Medical (ICCM) Slumps 4.64% as Support Levels LoomPSAR Stop - dars.gov.et
ICCM|Icecure Medical Ltd|Price:3.080|Chg%:-0.150 - TradingKey
Icecure Medical Ltd|Price:3.080|Chg%:-0.150 - TradingKey
TradingKey - TradingKey
Why Has IceCure Medical's Stock Price Collapsed - Kavout | AI
What's going on with IceCure Medical stock on Friday? - MSN
IceCure Medical Faces Sharp Decline: ICCM Drops 9.6% as Support Levels Are TestedLarge Cap Trends - dars.gov.et
Price to sales forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Meir Peleg Net Worth (2026) - GuruFocus
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation - Sahm
ICCM: First FDA-cleared minimally invasive cryoablation device for breast cancer, driving global growth - TradingView
IceCure Medical (ICCM) Expands U.S. Team to Meet Growing Demand for ProSense® System - GuruFocus
IceCure Medical (ICCM) Expands Sales and Marketing Teams Nationw - GuruFocus
Enterprise value to revenue forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer - AOL.com
IceCure Medical Ltd. emphasized that following FDA approval for breast cancer treatment, the commercial application of its Prosense™ cryoablation system is continuously expanding in Brazil. - Bitget
IceCure Medical (ICCM) Expands Presence in Brazil with ProSense System - GuruFocus
IceCure Medical Highlights Expanding Commercial Adoption Of ProSense Cryoablation In Brazil Following FDA Clearance For Breast Cancer - marketscreener.com
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer - Barchart.com
[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan
IceCure Medical (ICCM) Gains Ground: Support Holds, Resistance AheadMAMA Signal - DonanımHaber
Enterprise value to EBITDA forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Price to earnings forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Warrant repricing at IceCure Medical (NASDAQ: ICCM) heads to shareholder vote - Stock Titan
IceCure Medical Ltd. Actuals & Estimates (NASDAQ:ICCM) - TradingView
IceCure regains compliance with NASDAQ - MSN
IceCure regains compliance with Nasdaq MBP requirement - Medical Buyer
IceCure Medical Faces Certified Class Action Over 2021 Private Placement, Plans Court Challenge - The Globe and Mail
Why Is IceCure (NASDAQ:ICCM) Catching Small-Cap Attention? - Kalkine Media
IceCure Medical Ltd. Actuals & Estimates (BOATS:ICCM) - TradingView
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan
What's Going On With IceCure Medical Stock On Friday? - Benzinga
IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
Icecure Medical(ICCM) Stock Options Chain | Quotes & News - Moomoo
IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice - marketscreener.com
ICCM: Selling Stockholders Plan to Offer 5.5 Million Shares - GuruFocus
IceCure Medical (ICCM) registers 5.5M shares tied to June 2026 warrants - Stock Titan
ICCM Forecast — Price Target — Prediction for 2027 - TradingView
IceCure Medical Ltd (ICCM) stock price, news, quote and history - Yahoo Finance Australia
IceCure Medical (Nasdaq: ICCM) back in compliance with bid price rule - Stock Titan
Icecure Medical Ltd (ICCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
11.95%
자본화:
|
볼륨(24시간):